CXCR1 and cancer: As inhibition of IL8 receptor CXCR1/2 with reparixin diminished CSC tumorsphere forming and cancer cell migration induced by autocrine inflammatory forward-feedback loop (Figures 4c and d), we then asked whether reparixin would inhibit CSC enrichment after paclitaxel withdrawal in vitro.